PLASMA CELL LEUKEMIA
Clinical trials for PLASMA CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for PLASMA CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged immune cells take on hard-to-treat blood cancers
Disease control Recruiting nowThis study tests a new treatment for people with certain blood cancers (like leukemia, lymphoma, or multiple myeloma) that have come back or not responded to standard therapy. Participants receive chemotherapy followed by specially engineered natural killer (NK) cells from a dono…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:39 UTC
-
Slow and steady: new hope for frail myeloma patients
Disease control Recruiting nowThis study tests a 'go-slow' approach for ultra-frail patients newly diagnosed with multiple myeloma. Instead of starting all drugs at once, treatment begins with just two medications, adding a third after two months. The goal is to help these vulnerable patients stick with thera…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated May 26, 2026 06:22 UTC
-
Promising new combo therapy targets rare blood cancer
Disease control Recruiting nowThis study tests a powerful treatment plan for people newly diagnosed with a rare and aggressive blood cancer called primary plasma cell leukemia. The approach combines standard chemotherapy drugs with two rounds of CAR T-cell therapy and a stem cell transplant. The goal is to se…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 06:21 UTC
-
Early access to promising blood cancer drug for those with no other options
Disease control AVAILABLEThis program provides early access to venetoclax, a targeted therapy for several blood cancers including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and multiple myeloma. It is for people who have no other suitable treatments and cannot join a clinical trial…
Matched conditions: PLASMA CELL LEUKEMIA
Sponsor: AbbVie • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New hope for myeloma patients: drug may stop Transplant-Related diarrhea
Symptom relief Recruiting nowThis study tests whether a medication called budesonide can prevent severe diarrhea in people with multiple myeloma who are getting a stem cell transplant. About 120 adults will be randomly assigned to receive either budesonide or a placebo alongside standard care. The goal is to…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 26, 2026 06:32 UTC
-
New registry tracks frailty in older blood cancer patients
Knowledge-focused Recruiting nowThis study is building a registry of 5,000 adults aged 50 and older with blood cancers like multiple myeloma and lymphoma. Researchers will collect information on frailty, muscle loss, and other age-related health issues. No treatments are given—the goal is to gather data to supp…
Matched conditions: PLASMA CELL LEUKEMIA
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 26, 2026 06:38 UTC
-
New registry aims to unlock secrets of plasma cell disorders
Knowledge-focused Recruiting nowThis study is building a registry of 2,000 adults with plasma cell disorders, such as multiple myeloma and amyloidosis. Participants will fill out health questionnaires and may give a blood sample to study aging markers. The goal is to gather information to support future researc…
Matched conditions: PLASMA CELL LEUKEMIA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC
-
6,000 patients join global effort to unlock Myeloma's secrets
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 6,000 people with multiple myeloma, smoldering myeloma, plasma cell leukemia, or MGUS. Researchers will store these samples in a biobank to study the diseases and improve future care. Participants do not receive any treatment as p…
Matched conditions: PLASMA CELL LEUKEMIA
Sponsor: European Myeloma Network B.V. • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC